This section includes:

See the Resources/Partner Organizations section for a list of other organizations that work on access to medicines issues.


AMSA's Official Position on Issues

AMSA has taken a stand on issues of access to medicines, and these positions are listed in detail in our Constitution (also called the Preamble, Purposes, and Principles, or PPP) . This document is written by medical students, and amended only by vote of the official decision-making body of the Association, the House of Delagates.


Projects in a Box

  • AMSA's "Improving Access to Medicines in Developing Countries: What Can You Do at Your University?" (zip file that includes many files listed below)
  • AMSA's World AIDS Day (WAD) 2008 - overview and toolkit
  • Student Global AIDS Campaign (SGAC) - Universal Access 2010 Campaign


Education, Policy, and Direct Action Tools


Issue Specific Resources



Access to HIV/AIDS Medicines

Patents / Trade


Research Gap / Negected Diseases

  • Trouiller, P, Olliaro P, Torreele E, Orbinski J, Laing R, Ford N. "Drug development for neglected diseases: a deficient market and a public-health policy failure." Lancet. 2002 Jun 22;359(9324):2188-94.
  • Pecoul, B. "New drugs for neglected diseases: from pipeline to patients." PLoS Med. 2004 Oct;1(1):e6. Epub 2004 Oct 19.
  • Moran, M. "A breakthrough in R&D for neglected diseases: new ways to get the drugs we need." PLoS Med. 2005 Sep;2(9): Epub 2005 Sep 8.
  • Gardner, C and Garner C, "Technology Licensing to Nontraditional Partners: Non-Profit Health Product Development Organizations for Better Global Health." Report from MIHR: Centre for the Management of Intellectual Property in Health Research and Development. See


Pricing / Generics

  • "Action needed to tackle the second wave of the AIDS drug pricing crisis." Medicins Sans Frontieres Report. 26 July, 2005. See
  • Wainberg, MA. "Generic HIV drugs--enlightened policy for global health." N Engl J Med. 2005 Feb 24;352(8):747-50. Yale Journal of Health Policy, Law, and Ethics. 2003; 3:293.
  • Havlir, DV, and Hammer SM. "Patents versus patients? Antiretroviral therapy in India." N Engl J Med. 2005 Aug 25;353(8):749-51.


Role of Universities / Technology Transfer